Doctors and scientists are still trying to find a cure for HIV/AIDS ailment. But even so, a person afflicted with this disease still has a chance to live normally since there are treatments and anti-viral drugs that can help in suppressing the human immunodeficiency virus.
Although they are not really the HIV/AIDS cure that the world is searching for, they can at least minimize the effects and progression of the disease. There is no cure yet as of this time, but luckily, some techniques and procedures are available today to make patients live comfortably and longer.
Shock and kill method
The shock and kill technique may sound like one of those tactics used in the military, but this is actually one of the procedures that scientists using today in their bid to find a cure for AIDS. HIV can hide and remain silent in the body as long as the patient takes antiretroviral therapy.
However, once he or she stops the therapy, the fatal virus will reactivate, multiply, and then eventually spread in the body again. The Shock and Kill are used to “wake up” the dormant virus, and once they are all awake, they will be killed; thus, the whole group of the HIV will be destroyed all at once and in one go. The downside is that when one virus survives, it can multiply again and live in the patient’s body.
The Lock and Block method
This method traps the virus in its reservoir cell so it will stay there and will not be reactivated. The HIV is still in the body, but since it was trapped, it cannot come out and multiply, so the disease is controlled.
Stem-Cell Transplant
This is not considered as HIV/AIDS cure, yet even if it was reported that two patients used this stem-cell therapy method and were cured. The reason why this is not yet listed as a “cure” is because not all of those who have the virus responded well to this treatment. The same method was tried on other patients, but only two have gotten rid of the HIV virus in their body, which caused their AIDS illness.


AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Trump Signs Order to Cut Routine Childhood Vaccines
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
New York Declares Measles Disaster Emergency as Cases Surge
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal 



